LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike

Enhancing Phosphotyrosine Proteome Coverage using a Combined ETD and CID Approach on a LTQ Orbitrap XL ETD

Applications | 2016 | Thermo Fisher ScientificInstrumentation
LC/HRMS, LC/MS, LC/MS/MS, LC/Orbitrap, LC/IT
Industries
Proteomics
Manufacturer
Thermo Fisher Scientific

Summary

Importance of the Topic


Protein tyrosine phosphorylation governs key cellular processes such as growth, differentiation and migration. Dysregulation of tyrosine kinase and phosphatase activities is implicated in cancer and other diseases, but the low abundance and dynamic nature of phosphotyrosine peptides make their detection challenging. Enhanced analytical strategies are crucial to map tyrosine phosphorylation sites comprehensively and to support both basic research and clinical applications.

Study Objectives and Overview


This study compares two fragmentation workflows on an LTQ Orbitrap XL ETD mass spectrometer for phosphotyrosine peptide identification: (1) a classical approach performing both collision-induced dissociation (CID) and electron transfer dissociation (ETD) on every precursor, and (2) a data-dependent decision tree (DDDT) method that selects CID or ETD in real time based on the peptide’s m/z and charge state. The aim is to maximize sequence coverage and accurate phosphorylation site localization while optimizing instrument time.

Methodology


HeLa cells were treated with pervanadate to induce global tyrosine phosphorylation. Proteins were denatured in urea, reduced, alkylated, and enzymatically digested. Peptides were enriched by anti-phosphotyrosine immuno-affinity chromatography. Two LC-MS/MS runs were performed: (a) classical dual fragmentation of each precursor by CID and ETD, and (b) DDDT-guided CID for doubly charged and m/z-specific ETD for higher charge states.

Instrumentation


  • Thermo Scientific LTQ Orbitrap XL ETD: high-resolution orbitrap full scans, linear ion trap MS/MS by CID or ETD with supplemental activation.
  • Agilent 1100 nanoflow HPLC: trap column (AQUA C18) and analytical column (ReproSil-Pur C18-AQ) with a 3-hour acetonitrile gradient.
  • Thermo Proteome Discoverer and Mascot search engine for spectral processing and database searches.

Main Results and Discussion


The classical method identified 154 unique phosphotyrosine peptides (Mascot score ≥20), with 56% detected by both CID and ETD. CID alone accounted for 35 peptides and ETD for 32. The DDDT workflow increased total identifications by 30%, yielding 200 unique peptides: 128 by CID only, 51 by ETD only, and 26 by both. Example spectra illustrate that ETD excels with highly charged and longer peptides, preserving labile modifications, while CID performs best on doubly charged precursors. Intelligent selection of fragmentation improved site localization and sequencing confidence without doubling run time.

Benefits and Practical Applications


The combined CID/ETD strategy with DDDT logic enhances phosphotyrosine proteome coverage and confidence in site assignment. This approach is valuable in phosphoproteomics studies of signaling pathways, drug target validation and biomarker discovery, where efficient use of instrument time and deep coverage are essential.

Future Trends and Potential Applications


  • Refinement of decision tree algorithms and machine-learning-driven fragmentation selection.
  • Integration with higher-performance mass spectrometers for deeper phosphoproteome analysis.
  • Application to other labile post-translational modifications and broader quantitative workflows.
  • Automation of enrichment and data processing pipelines to increase throughput.

Conclusion


Intelligent use of CID and ETD fragmentation guided by a data-dependent decision tree on an LTQ Orbitrap XL ETD significantly improves phosphotyrosine peptide identification and site localization compared to classical dual fragmentation. This optimized workflow offers a powerful tool for comprehensive phosphoproteomic investigations.

References


  • Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature. 2001;411:355-365.
  • Pinkse MW et al. Highly robust, automated, and sensitive online TiO2-based phosphoproteomics in Drosophila melanogaster. J Proteome Res. 2008;7:687-697.
  • Ficarro SB et al. Phosphoproteome analysis by mass spectrometry in Saccharomyces cerevisiae. Nat Biotechnol. 2002;20:301-305.
  • Van Hoof D et al. Phosphorylation dynamics during early differentiation of human embryonic stem cells. Cell Stem Cell. 2009;5:214-226.
  • Rush J et al. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol. 2005;23:94-101.
  • Zhang Y et al. Time-resolved mass spectrometry of tyrosine phosphorylation in EGFR signaling. Mol Cell Proteomics. 2005;4:1240-1250.
  • Boersema PJ et al. Profiling of tyrosine phosphorylation by immunoaffinity and dimethyl labeling. Mol Cell Proteomics. 2010;9:84-99.
  • Steen H et al. Tyrosine phosphorylation mapping of EGFR signaling. J Biol Chem. 2002;277:1031-1039.
  • Swaney DL, McAlister GC, Coon JJ. Decision tree-driven tandem MS for shotgun proteomics. Nat Methods. 2008;5:959-964.
  • Boersema PJ, Mohammed S, Heck AJ. Phosphopeptide fragmentation by MS. J Mass Spectrom. 2009;44:861-878.
  • Zeller M et al. Increasing proteome coverage with ETD and CID using intelligent decision tree logic. Thermo Scientific Application Note 30179. 2010.

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Toggle
Global In-Depth Quantitative Phosphoproteomic Analysis of HIV Infected Cells using the Orbitrap Fusion Tribrid Mass Spectrometer
Global In-Depth Quantitative Phosphoproteomic Analysis of HIV Infected Cells using the Orbitrap Fusion Tribrid Mass Spectrometer Eliuk S1, Johnson J2, Zabrouskov V1, Krogan N2 1Thermo Fisher Scientific, San Jose, CA, 2University of California San Francisco, CA Overview Purpose: To determine…
Key words
hiv, hivcid, cidphosphopeptides, phosphopeptidesdddt, dddtinfected, infectedsilac, silacetd, etdjurkat, jurkatlocalization, localizationcells, cellsphosphosite, phosphositeimmunodeficiency, immunodeficiencyphosphoproteome, phosphoproteomeinfection, infectionhuman
Evaluation of search engines for phosphopeptide identification and quantitation
Poster Note 64793 Evaluation of search engines for phosphopeptide identification and quantitation Evaluation of of search searchengines enginesfor forphosphope phosphop Evaluation Xiaoyue Jiang1, David Horn1, Ryan Bomgarden2 ,Tara Schroeder3, Rosa Viner1, Andreas FR Huhmer1 Thermo Fisher Scientific, San Jose, CA;…
Key words
phosphopeptide, phosphopeptidecid, cidethcd, ethcdmsa, msahcd, hcdfragmentation, fragmentationsearch, searchidentifications, identificationsmaxquant, maxquantphosphopeptides, phosphopeptidesbyonic, byonicsequest, sequestengines, enginesmascot, mascotproteome
A Novel, Automated, and Highly Selective Phosphopeptide Enrichment for Phosphopeptide Identification and Phosphosite Localization
Application Note Proteomics A Novel, Automated, and Highly Selective Phosphopeptide Enrichment for Phosphopeptide Identification and Phosphosite Localization Authors Valery G. Voinov and Joseph S. Beckman e-MSion Inc. Corvallis, OR, USA Shuai Wu, Kenneth Newton, Linfeng Wu, and Jordy J. Hsiao…
Key words
phosphopeptide, phosphopeptidevveavnsdsdsefgipk, vveavnsdsdsefgipkphosphopeptides, phosphopeptidesenrichment, enrichmentyeast, yeastpeptide, peptideenriched, enrichedecd, ecdassaymap, assaymapnonphosphopeptide, nonphosphopeptidewere, werephosphorylation, phosphorylationphosphorylated, phosphorylatedphosphosite, phosphositeprecursor
MAPPING PHOSPHORYLATION OF PEPTIDE BIOMARKERS CORRESPONDING WITH GLIOBLASTOMA TUMOURS USING DDA AND A NOVEL MRT MASS SPECTROMETER
MAPPING PHOSPHORYLATION OF PEPTIDE BIOMARKERS CORRESPONDING WITH GLIOBLASTOMA TUMOURS USING DDA AND A NOVEL MRT MASS SPECTROMETER Matthew E. Daly1, Nikka Atwal1 Lee A. Gethings1, Christopher J. Hughes1, Richard Lock1, Hamida Mussa2 and Nelofer Syed2 1 Waters Corporation, Wilmslow, UK.…
Key words
glioblastoma, glioblastomamrt, mrtphosphorylated, phosphorylatedlines, linesnta, ntaxevo, xevoacquisition, acquisitiondependent, dependentcell, cellsuccessfully, successfullyprofiled, profiledpremier, premierphosphopeptides, phosphopeptidestreated, treatedphosphopeptide
Other projects
GCMS
ICPMS
Follow us
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike